Willkie Farr & Gallagher | Asian Legal Business

瑞格、Willkie Farr、德杰、金杜助力施乐15亿美元收购中资公司利盟国际（ZH/EN）

BY Hu Yangxiaoxiao 胡阳潇潇 | 30 Dec 24

12月23日，美国办公设备制造商施乐宣布，其将以15亿美元，从纳思达公司、太盟亚洲资本和上海首达投资中心处收购利盟100%股权。此次收购后，利盟将重新变为一家美国公司。

Davis Polk, Willkie on Huatai Securities’ $780 mln buyout of U.S. fintech biz AssetMark

BY Shangjing Li | 13 Apr 16

Davis Polk & Wardwell has advised Huatai Securities on a $780 million deal with private equity firms Genstar Capital and Aquiline Capital Partners to purchase U.S. financial technology company AssetMark Financial Holdings

Plethora of U.S., PRC firms on $3.3 bln WuXi PharmaTech take-private deal

BY Eileen Ang | 25 Aug 15

O’Melveny & Myers, Willkie Farr & Gallagher, Walkers Global and Zhong Lun Law Firm are advising NYSE-listed Chinese clinical research organization WuXi PharmaTech on its agreement to be bought by a Chinese investor consortium for $3.3 billion.

North Asia Deals: Week of June 15

BY Karuna Jainpalli | 18 Jun 15

S&C, Willkie Farr & Gallagher, Debevoise on Tokio Marine’s $7.5 billion insurance buy, Paul Hastings acts on Bluestar Finance’s notes issuance, and more in this week’s North Asia Deals table.